French pharmaceutical firm Sanofi has signed a Memorandum of Cooperation (MoC) with the Iran Food and Drug Administration, affiliated to the Ministry of Health and Medical Education of Iran, in order to increase its presence in the country.

The MoC is aimed at initiating talks to explore the possibilities where the company may provide its expertise for several projects, which will be studied to further develop existing local manufacturing collaborations and work on programmes to fight chronic and non-communicable diseases.

As part of the deal, the French firm would extend partnerships with local manufacturers to improve the sharing of its expertise in industrial quality standards and increase the transfer of pharmaceutical production technology and know-how.

The company will also collaborate with Iran’s Ministry of Health on programmes to avoid and control several chronic and non-communicable diseases, as well as on managing associated risk factors like diabetes.

"With this cooperation, we will consider the possibility to increase our footprint in Iran … and reinforce our ongoing industrial collaborations."

It will also evaluate potential collaborations to enhance the availability of exact epidemiological studies and registries.

The company noted that all assessments will be carried out in accordance with applicable laws, including trade restriction rules.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Sanofi board of directors chairman Serge Weinberg said: "With this cooperation, we will consider the possibility to increase our footprint in Iran, where we have been operating for more than ten years, and reinforce our ongoing industrial collaborations."

Both Sanofi and Iran Ministry of Health agree that the collaboration is critical to permit policy makers to create and shape effective and socially impactful policies in the health sector.

The deal will see Sanofi’s provide its extensive knowledge in epidemiological studies and registries on both national and international scales to the Ministry of Health, in order to help policy makers to address the chronic and non-communicable diseases areas such as diabetes, cardiovascular diseases, multiple sclerosis and rare diseases.